Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 168

1.

Medication-induced osteoporosis: screening and treatment strategies.

Panday K, Gona A, Humphrey MB.

Ther Adv Musculoskelet Dis. 2014 Oct;6(5):185-202. doi: 10.1177/1759720X14546350. Review.

PMID:
25342997
[PubMed]
Free PMC Article
2.

The use of dietary supplements to alleviate androgen deprivation therapy side effects during prostate cancer treatment.

Dueregger A, Heidegger I, Ofer P, Perktold B, Ramoner R, Klocker H, Eder IE.

Nutrients. 2014 Oct 21;6(10):4491-519. doi: 10.3390/nu6104491.

PMID:
25338271
[PubMed - in process]
Free PMC Article
3.

Sex steroid actions in male bone.

Vanderschueren D, Laurent MR, Claessens F, Gielen E, Lagerquist MK, Vandenput L, Börjesson AE, Ohlsson C.

Endocr Rev. 2014 Dec;35(6):906-60. doi: 10.1210/er.2014-1024. Epub 2014 Sep 9.

PMID:
25202834
[PubMed - in process]
Free PMC Article
4.

Health care costs for prostate cancer patients receiving androgen deprivation therapy: treatment and adverse events.

Krahn MD, Bremner KE, Luo J, Alibhai SM.

Curr Oncol. 2014 Jun;21(3):e457-65. doi: 10.3747/co.21.1865.

PMID:
24940106
[PubMed]
Free PMC Article
5.

Complications de l'hormonothérapie anti-androgénique du cancer de la prostate.

Ziouziou I, Karmouni T, Khader KE, Koutani A, Andaloussi AI.

Can Urol Assoc J. 2014 Mar;8(3-4):E159-E162. Review. French. No abstract available.

PMID:
24678355
[PubMed - as supplied by publisher]
Free PMC Article
6.

Caring for Alaska Native prostate cancer survivors in primary care: a survey of Alaska Tribal Health System providers.

Tilburt JC, Kelley S, DeCourtney CA, Humeniuk KM, Latini J, Kim SP.

Int J Circumpolar Health. 2014 Feb 27;73:23637. doi: 10.3402/ijch.v73.23637. eCollection 2014.

PMID:
24596707
[PubMed - in process]
Free PMC Article
7.

Bone targeted therapies for the prevention of skeletal morbidity in men with prostate cancer.

Saylor PJ.

Asian J Androl. 2014 May-Jun;16(3):341-7. doi: 10.4103/1008-682X.122591. Review.

PMID:
24435057
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Androgens and estrogens in skeletal sexual dimorphism.

Laurent M, Antonio L, Sinnesael M, Dubois V, Gielen E, Classens F, Vanderschueren D.

Asian J Androl. 2014 Mar-Apr;16(2):213-22. doi: 10.4103/1008-682X.122356. Review.

PMID:
24385015
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Effects of recreational soccer in men with prostate cancer undergoing androgen deprivation therapy: study protocol for the 'FC Prostate' randomized controlled trial.

Uth J, Schmidt JF, Christensen JF, Hornstrup T, Andersen LJ, Hansen PR, Christensen KB, Andersen LL, Helge EW, Brasso K, Rørth M, Krustrup P, Midtgaard J.

BMC Cancer. 2013 Dec 13;13:595. doi: 10.1186/1471-2407-13-595.

PMID:
24330570
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Exercise effects on adipokines and the IGF axis in men with prostate cancer treated with androgen deprivation: A randomized study.

Mina DS, Connor MK, Alibhai SM, Toren P, Guglietti C, Matthew AG, Trachtenberg J, Ritvo P.

Can Urol Assoc J. 2013 Nov-Dec;7(11-12):E692-8. doi: 10.5489/cuaj.235.

PMID:
24282459
[PubMed]
Free PMC Article
11.

Efficacy and safety of high-dose-rate brachytherapy of single implant with two fractions combined with external beam radiotherapy for hormone-naïve localized prostate cancer.

Noda Y, Sato M, Shirai S, Kishi K, Inagaki T, Mori T, Hara I.

Cancers (Basel). 2011 Sep 14;3(3):3585-600. doi: 10.3390/cancers3033585.

PMID:
24212968
[PubMed]
Free PMC Article
12.

Optimizing bone health and minimizing skeletal morbidity in men with prostate cancer.

McKay RR, Taplin ME, Choueiri TK.

Hematol Oncol Clin North Am. 2013 Dec;27(6):1261-83, ix. doi: 10.1016/j.hoc.2013.08.009. Epub 2013 Sep 20. Review.

PMID:
24188262
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Systematic screen with kinases inhibitors reveals kinases play distinct roles in growth of osteoprogenitor cells.

Bao NR, Lu M, Bin FW, Chang ZY, Meng J, Zhou LW, Guo T, Zhao JN.

Int J Clin Exp Pathol. 2013 Sep 15;6(10):2082-91. eCollection 2013.

PMID:
24133586
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Treatment of osteoporosis in men with bisphosphonates: rationale and latest evidence.

Sim IeW, Ebeling PR.

Ther Adv Musculoskelet Dis. 2013 Oct;5(5):259-67. doi: 10.1177/1759720X13500861.

PMID:
24101947
[PubMed]
Free PMC Article
15.

CUA-CUOG guidelines for the management of castration-resistant prostate cancer (CRPC): 2013 update.

Saad F, Hotte S, Catton C, Drachenberg D, Finelli A, Fleshner N, Gleave M, Kapoor A, Kassouf W, Loblaw A, North S, Usmani N, Chi KN.

Can Urol Assoc J. 2013 Jul-Aug;7(7-8):231-7. doi: 10.5489/cuaj.1542. No abstract available. Erratum in: Can Urol Assoc J. 2013 Sep;7(9-10):301.

PMID:
24032056
[PubMed]
Free PMC Article
16.

Causes, consequences, and treatment of osteoporosis in men.

Banu J.

Drug Des Devel Ther. 2013 Aug 22;7:849-60. doi: 10.2147/DDDT.S46101. eCollection 2013. Review.

PMID:
24009413
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Treatment and Mortality in Men with Localized Prostate Cancer: A Population-Based Study in California.

Sieh W, Lichtensztajn DY, Nelson DO, Cockburn M, West DW, Brooks JD, Chang ET.

Open Prost Cancer J. 2013;6:1-9.

PMID:
23997838
[PubMed]
Free PMC Article
18.

Adverse effects of androgen deprivation therapy for prostate cancer: prevention and management.

Sountoulides P, Rountos T.

ISRN Urol. 2013 Jul 25;2013:240108. doi: 10.1155/2013/240108. eCollection 2013.

PMID:
23984103
[PubMed]
Free PMC Article
19.

Clinical experience with intravenous zoledronic acid in the treatment of male osteoporosis: evidence and opinions.

Ruza I, Mirfakhraee S, Orwoll E, Gruntmanis U.

Ther Adv Musculoskelet Dis. 2013 Aug;5(4):182-98. doi: 10.1177/1759720X13485829.

PMID:
23904863
[PubMed]
Free PMC Article
20.

Efficacy of intermittent androgen deprivation therapy vs conventional continuous androgen deprivation therapy for advanced prostate cancer: a meta-analysis.

Tsai HT, Penson DF, Makambi KH, Lynch JH, Van Den Eeden SK, Potosky AL.

Urology. 2013 Aug;82(2):327-33. doi: 10.1016/j.urology.2013.01.078.

PMID:
23896094
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk